🧬#Sefaxersen targets complement #FactorB mRNA, reducing FactorB and blocking the alternative pathway. Now in Phase3 IMAGINATION, this #RNAtherapy offers high specificity, long-acting effects, and potential disease-modifying benefits for kidney disease.
#Kidney #PrecisionMedicine